Clinical utility of a coronary heart disease risk prediction gene score in UK healthy middle aged men and in the Pakistani population

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Beaney, Katherine E ^a   Cooper, Jackie A ^a   Shahid, Saleem Ullah ^b   Ahmed, Waqas ^c   Qamar, Raheel ^d   Drenos, Fotios ^a,e   Crockard, Martin A ^f   Humphries, Steve E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c KPK   (Pakistan)

^d COMSATS Institute of Information Technology ^*  (Pakistan)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f Randox Laboratories Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRITISH CITIZEN; CARDIOVASCULAR RISK; CLASSIFICATION; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; FRAMINGHAM RISK SCORE; GENE FREQUENCY; GENE LOCUS; GENE SCORE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN GENOME; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PAKISTAN; PAKISTANI; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CAUCASIAN; CORONARY DISEASE; ETHNOLOGY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PATHOLOGY; PROGNOSIS; RISK FACTOR;

SPACER DNA;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY DISEASE; DNA, INTERGENIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PAKISTAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; UNITED KINGDOM;

EID: 84941012228     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130754     Document Type: Article

References (44)

1. Cooper JA, Miller GJ, Humphries SE. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005; 181(1):93-100. doi: 10.1016/j.atherosclerosis.2004.12.026 WOS:000230215300012. PMID: 15939059
2. Miller GJ, Bauer KA, Barzegar S, Foley AJ, Mitchell JP, Cooper JA, et al. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb Haemost. 1995; 73(1):82-6. Epub 1995/01/01. PMID: 7740501.
3. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010; 35(2):72-115. Epub 2010/01/30. doi: 10.1016/j.cpcardiol.2009.10.002 PMID: 20109979; PubMed Central PMCID: PMC2864143.
4. Aziz K, Faruqui A, Patel N, Jaffery H. Prevalence and Awareness of Cardiovascular Disease Including Lifestyles in a Lower Middle Class Urban Community in an Asian Country Pakistan Heart Journal. 2008; 41(3-4):11-20.
5. Jafar TH, Qadri Z, Chaturvedi N. Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. Heart. 2008; 94(4):408-13. Epub 2007/07/25. doi: 10.1136/hrt.2007.120774 PMID: 17646192; PubMed Central PMCID: PMC2565583.
6. Wood D, Wray R, Poulter N, Williams B, Kirby M, Patel V, et al. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005;91. doi: 10.1136/hrt.2005.079988 WOS:000234060500001.
7. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. New Engl J Med. 2007; 356(23):2388-98. Epub 2007/06/08. doi: 10.1056/NEJMsa053935 PMID: 17554120.
8. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS medicine. 2005; 2(6):e160. Epub 2005/06/25. doi: 10.1371/journal.pmed.0020160 PMID: 15974805; PubMed Central PMCID: PMC1160573.
9. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J. 2013; 34(10):719-28. Epub 2012/12/18. doi: 10.1093/eurheartj/ehs411 PMID: 23242196.
10. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. Epub 1998/05/29. PMID: 9603539.
11. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3 WOS:000183577800002. PMID: 12788299
12. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008; 336 (7659):1475-82. Epub 2008/06/25. doi: 10.1136/bmj.39609.449676.25 PMID: 18573856; PubMed Central PMCID: PMC2440904.
13. Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr., Gibbons R, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013. Epub 2013/11/14. doi: 10.1161/01.cir.0000437741.48606.98 PMID: 24222018.
14. National Institute for Health and Care Excellence: Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. 2014.
15. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ. 2010; 340:c2442. Epub 2010/05/15. doi: 10.1136/bmj.c2442 PMID: 20466793; PubMed Central PMCID: PMC2869403.
16. Peden JF, Farrall M. Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet. 2011; 20(R2):R198-205. Epub 2011/08/31. doi: 10.1093/hmg/ddr384 PMID: 21875899; PubMed Central PMCID: PMC3179381.
17. Casas JP, Cooper J, Miller GJ, Hingorani AD, Humphries SE. Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Ann Hum Genet. 2006; 70(Pt 2):145-69. Epub 2006/04/22. doi: 10.1111/j.1469-1809.2005.00241.x PMID: 16626327.
18. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013; 45(1):25-U52. doi: 10.1038/ng.2480 WOS:000312838800009. PMID: 23202125
19. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem. 2008; 54(3):467-74. doi: 10.1373/clinchem.2007.095489 WOS:000253570400005. PMID: 18250146
20. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circulation Cardiovascular genetics. 2009; 2(3):279-85. Epub 2009/12/25. doi: 10.1161/CIRCGENETICS.108.817338 PMID: 20031596; PubMed Central PMCID: PMC2771929.
21. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009; 150(2):65-72. Epub 2009/01/21. PMID: 19153409; PubMed Central PMCID: PMC2629586.
22. Davies RW, Dandona S, Stewart AF, Chen L, Ellis SG, Tang WH, et al. Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circulation Cardiovascular genetics. 2010; 3(5):468-74. Epub 2010/08/24. doi: 10.1161/CIRCGENETICS.110.946269 PMID: 20729558; PubMed Central PMCID: PMC3035486.
23. Hughes MF, Saarela O, Stritzke J, Kee F, Silander K, Klopp N, et al. Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts. PLoS One. 2012; 7(7). doi: 10.1371/journal.pone.0040922. WOS:000306806600029.
24. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
25. R Core Team. R: A language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org/. 2014.
26. IBMCorp. IBM SPSS Statistics for Windows, Version 22.0. 22.0 ed. Armonk, NY: IBM 2013.
27. Talmud PJ, Palmen J, Putt W, Lins L, Humphries SE. Determination of the functionality of common APOA5 polymorphisms. J Biol Chem. 2005; 280(31):28215-20. Epub 2005/06/09. doi: 10.1074/jbc.M502144200 PMID: 15941721.
28. Linsel-Nitschke P, Heeren J, Aherrahrou Z, Bruse P, Gieger C, Illig T, et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis. 2010; 208(1):183-9. doi: 10.1016/j.atherosclerosis.2009.06.034 WOS:000273567300031. PMID: 19660754
29. The International HapMap Project. Nature. 2003; 426(6968):789-96. Epub 2003/12/20. doi: 10.1038/nature02168 PMID: 14685227.
30. Saleheen D, Alexander M, Rasheed A, Wormser D, Soranzo N, Hammond N, et al. Association of the 9p21.3 Locus With Risk of First-Ever Myocardial Infarction in Pakistanis Case-Control Study in South Asia and Updated Meta-Analysis of Europeans. Arterioscl Throm Vas. 2010; 30(7):1467-U498. doi: 10.1161/atvbaha.109.197210 WOS:000278856600026.
31. Lanktree MB, Anand SS, Yusuf S, Hegele RA. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circulation Cardiovascular genetics. 2010; 3(1):39-46. Epub 2010/02/18. doi: 10.1161/CIRCGENETICS.109.907642 PMID: 20160194.
32. Schierer A, Been LF, Ralhan S, Wander GS, Aston CE, Sanghera DK. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort. Pharmacogenet Genomics. 2012; 22(2):95-104. Epub 2011/12/07. doi: 10.1097/FPC.0b013e32834dc9ef PMID: 22143414; PubMed Central PMCID: PMC3269125.
33. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. Epub 2012/11/07. doi: 10.1038/nature11632 PMID: 23128226; PubMed Central PMCID: PMC3498066.
34. Iqbal R, Jahan N, Sun Y, Xue H. Genetic association of lipid metabolism related SNPs with myocardial infarction in the Pakistani population. Mol Biol Rep. 2014; 41(3):1545-52. Epub 2014/01/10. doi: 10.1007/s11033-013-3000-x PMID: 24402875.
35. Hedrick PW. Genetics of Populations. 4th ed. Sudbury, Mass.; London: Jones and Bartlett Publishers, Inc; 2011.
36. Kathiresan S, Altschuler D, Anand S, Ardissino D, Asselta R, Ball SG, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3):334-41. doi: 10.1038/ng.327 WOS:000263640200023. PMID: 19198609
37. Harrison SC, Cooper JA, Li K, Talmud PJ, Sofat R, Stephens JW, et al. Association of a sequence variant in DAB2IP with coronary heart disease. Eur Heart J. 2012; 33(7):881-8. doi: 10.1093/eurheartj/ehr075 WOS:000302497800020. PMID: 21444365
38. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. New Engl J Med. 2007; 357(5):443-53. doi: 10.1056/NEMJoa072366 WOS:000248436300005. PMID: 17634449
39. Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010; 375(9726):1634-9. Epub 2010/05/11. doi: 10.1016/S0140-6736(10)60545-4 PMID: 20452521; PubMed Central PMCID: PMC2867029.
40. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, et al. Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease. New Engl J Med. 2009; 361(26):2518-28. doi: 10.1056/NEJMoa0902604 WOS:000273003700007. PMID: 20032323
41. Erdmann J, Grosshennig A, Braund PS, Konig IR, Hengstenberg C, Hall AS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet. 2009; 41(3):280-2. doi: 10.1038/ng.307 WOS:000263640200006. PMID: 19198612
42. Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, van Maarle M, et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol. 2008; 168(11):1233-46. Epub 2008/10/17. doi: 10.1093/aje/kwn235 PMID: 18922999.
43. Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol. 2010; 55(25):2833-42. Epub 2010/06/29. doi: 10.1016/j.jacc.2010.02.044 PMID: 20579540.
44. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007; 298(11):1300-11. Epub 2007/09/20. doi: 10.1001/jama.298.11.1300 PMID: 17878422.